These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20121832)

  • 21. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia.
    Tripathi R; Rath G; Jain A; Salhan S
    Ann Anat; 2008 Nov; 190(5):477-89. PubMed ID: 18992679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study.
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):144-51. PubMed ID: 22280827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic balance in pregnancy and subsequent breast cancer risk and survival: a population study.
    Vatten LJ; Romundstad PR; Jenum PA; Eskild A
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2074-8. PubMed ID: 19567504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks.
    Farina A; Zucchini C; Sekizawa A; Purwosunu Y; de Sanctis P; Santarsiero G; Rizzo N; Morano D; Okai T
    Am J Obstet Gynecol; 2010 Dec; 203(6):575.e1-7. PubMed ID: 20934680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Kuhnreich I; Meiri H
    Prenat Diagn; 2007 Mar; 27(3):258-63. PubMed ID: 17278173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of angiogenic factors in discriminating preeclampsia: are they ready for prime time?
    Srinivas SK; Larkin J; Sammel MD; Appleby D; Bastek J; Andrela CM; Ofori E; Elovitz MA
    J Matern Fetal Neonatal Med; 2010 Nov; 23(11):1294-300. PubMed ID: 20482287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia.
    Shimizu H; Sekizawa A; Purwosunu Y; Nakamura M; Farina A; Rizzo N; Okai T
    Prenat Diagn; 2009 Dec; 29(13):1231-6. PubMed ID: 19813218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.
    Farina A; Sekizawa A; De Sanctis P; Purwosunu Y; Okai T; Cha DH; Kang JH; Vicenzi C; Tempesta A; Wibowo N; Valvassori L; Rizzo N
    Prenat Diagn; 2008 Oct; 28(10):956-61. PubMed ID: 18792924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
    Savvidou MD; Noori M; Anderson JM; Hingorani AD; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Dec; 32(7):871-6. PubMed ID: 18814185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia.
    Sezer SD; Küçük M; Yenisey C; Yüksel H; Odabaşı AR; Türkmen MK; Çetinkaya Çakmak B; Ömürlü IK
    Gynecol Endocrinol; 2012 Aug; 28(8):628-32. PubMed ID: 22429154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of angiogenic biomarkers at ⩽20weeks' gestation in predicting the risk of pre-eclampsia: A WHO multicentre study.
    Widmer M; Cuesta C; Khan KS; Conde-Agudelo A; Carroli G; Fusey S; Karumanchi SA; Lapaire O; Lumbiganon P; Sequeira E; Zavaleta N; Frusca T; Gülmezoglu AM; Lindheimer MD
    Pregnancy Hypertens; 2015 Oct; 5(4):330-8. PubMed ID: 26597750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
    Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Geipel A; Schwarz F; Krämer T; Wessel N; Faber R
    Am J Obstet Gynecol; 2008 Feb; 198(2):175.e1-6. PubMed ID: 18226617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Profile of serum soluble endoglin in pregnant women with severe pre-eclampsia and eclampsia].
    Zhu YC; Sun Y; Yang HX; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):91-3. PubMed ID: 19570416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.
    Purwosunu Y; Sekizawa A; Yoshimura S; Farina A; Wibowo N; Nakamura M; Shimizu H; Okai T
    Reprod Sci; 2009 Sep; 16(9):857-64. PubMed ID: 19474289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.
    Bills VL; Varet J; Millar A; Harper SJ; Soothill PW; Bates DO
    Clin Sci (Lond); 2009 Feb; 116(3):265-72. PubMed ID: 18826376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
    Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia.
    López-Novoa JM
    Nephrol Dial Transplant; 2007 Mar; 22(3):712-4. PubMed ID: 17210583
    [No Abstract]   [Full Text] [Related]  

  • 39. Modification of angiogenic factors by regular and acute exercise during pregnancy.
    Weissgerber TL; Davies GA; Roberts JM
    J Appl Physiol (1985); 2010 May; 108(5):1217-23. PubMed ID: 20224004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women.
    Yu Y; Jenkins AJ; Nankervis AJ; Hanssen KF; Scholz H; Henriksen T; Lorentzen B; Clausen T; Garg SK; Menard MK; Hammad SM; Scardo JC; Stanley JR; Dashti A; May K; Lu K; Aston CE; Wang JJ; Zhang SX; Ma JX; Lyons TJ
    Diabetologia; 2009 Jan; 52(1):160-8. PubMed ID: 18985316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.